Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.
Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Falvo L, De Vito C, Catania A, Tartaglia F, Mocini R, Coccaro C, Alessandrini S, Barollo S, Mian C, Antonelli A, De Antoni E, D'Armiento M, Ulisse S. Baldini E, et al. Among authors: catania a. PLoS One. 2015 Mar 25;10(3):e0121514. doi: 10.1371/journal.pone.0121514. eCollection 2015. PLoS One. 2015. PMID: 25807528 Free PMC article.
Aurora kinases: new molecular targets in thyroid cancer therapy.
Baldini E, Sorrenti S, D'Armiento E, Prinzi N, Guaitoli E, Favoriti P, Gnessi L, Moretti C, Bianchini M, Alessandrini S, Catania A, De Antoni E, Ulisse S. Baldini E, et al. Among authors: catania a. Clin Ter. 2012 Nov;163(6):e457-62. Clin Ter. 2012. PMID: 23306762 Review.
Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells.
Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Antonelli A, Fallahi P, Mian C, Barollo S, Catania A, Morrone S, Tartaglia F, Mascagni D, Coccaro C, Pepe M, Filippini A, D'Armiento M, Ulisse S. Baldini E, et al. Among authors: catania a. J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):793-803. J Biol Regul Homeost Agents. 2015. PMID: 26753639
High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
Ulisse S, Baldini E, Sorrenti S, Barollo S, Gnessi L, Catania A, Pellizzo MR, Nardi F, Mian C, De Antoni E, D'Armiento M, Frati L. Ulisse S, et al. Among authors: catania a. J Clin Endocrinol Metab. 2011 Feb;96(2):504-8. doi: 10.1210/jc.2010-1688. Epub 2010 Nov 24. J Clin Endocrinol Metab. 2011. PMID: 21106716
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.
Ulisse S, Baldini E, Sorrenti S, Barollo S, Prinzi N, Catania A, Nesca A, Gnessi L, Pelizzo MR, Mian C, De Vito C, Calvanese A, Palermo S, Persechino S, De Antoni E, D'Armiento M. Ulisse S, et al. Among authors: catania a. Clin Endocrinol (Oxf). 2012 Nov;77(5):780-6. doi: 10.1111/j.1365-2265.2012.04465.x. Clin Endocrinol (Oxf). 2012. PMID: 22702340
477 results